Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 6/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 5/20 | 0.32 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.32 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.32 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | TERT | O14746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18017861 | 1.00 | ELANE (0.33) | ELANEADORA2AADORA1PLA2G2APLA2G4A | |
| SCHEMBL18017769 | 1.00 | ELANE (0.33) | ELANEADORA2AADORA1PLA2G2APLA2G4A | |
| SCHEMBL18017708 | 1.00 | ELANE (0.33) | ELANEADORA2AADORA1PLA2G2APLA2G4A | |
| SCHEMBL18017829 | 0.99 | ELANE (0.33) | ELANEADORA2AADORA1PLA2G2APLA2G4A | |
| SCHEMBL18018008 | 0.98 | PLA2G2A (0.33) | ELANEADORA2AADORA1PLA2G2APLA2G4A | |
| SCHEMBL18017949 | 0.97 | ADORA2A (0.33) | ELANEADORA2AADORA1PLA2G2APLA2G4A | |
| SCHEMBL18017970 | 0.97 | ADORA2A (0.33) | ELANEADORA2AADORA1PLA2G2APLA2G4A | |
| SCHEMBL18017946 | 0.97 | ADORA2A (0.33) | ELANEADORA2AADORA1PLA2G2APLA2G4A | |
| SCHEMBL18017982 | 0.97 | PLA2G2A (0.34) | ELANEADORA2AADORA1PLA2G2APLA2G4A | |
| SCHEMBL18017996 | 0.97 | PLA2G2A (0.34) | ELANEADORA2AADORA1PLA2G2APLA2G4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160240791-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2016-08-18 | — | — | US | disclosed |
| US-20160240791-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2016-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160240791-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | OR10J3, OXER1, OCIAD1 | ELANE 4062/4885ADORA2A 3675/4885ADORA1 2882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.